Albumin-paclitaxel Injection

DRUG3 trials

Sponsors

Chipscreen Biosciences, Ltd., Fudan University

Conditions

Metastatic Pancreatic Ductal AdenocarcinomaPaget Disease, ExtramammaryPancreatic Ductal AdenocarcinomaPenile CancerRhabdomyosarcomaTesticular CancerUrachal Cancer

Phase 2

Chiauranib in Patients With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma

Active, not recruitingNCT06492915

Chipscreen Biosciences, Ltd.Pancreatic Ductal Adenocarcinoma

Start: 2024-08-13End: 2026-10-31Target: 42Updated: 2026-03-18

Multi-cohort, Single-arm Phase II Study of Albumin-paclitaxel, Ifosfamide, and Cisplatin in the Treatment of Rare Advanced Tumors

RecruitingNCT06684327

Fudan UniversityPaget Disease, Extramammary, Penile Cancer, Rhabdomyosarcoma +2

Start: 2024-11-30End: 2027-12-30Target: 100Updated: 2024-12-20

Phase 3

Chiauranib Plus PD-1 Inhibitor, Albumin-paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Ductal Adenocarcinoma

Not yet recruitingNCT07445295

Chipscreen Biosciences, Ltd.Metastatic Pancreatic Ductal Adenocarcinoma

Start: 2026-03-31End: 2028-11-30Target: 558Updated: 2026-03-03